• 19057

Dr. Ranin Soliman

    Head of Health Economics & Value Unit

Head of Health Economics & Value Unit

COO Assistant for Health Economics

ORCID profile: https://orcid.org/0000-0001-8503-9067

CEBM profile: https://www.cebm.ox.ac.uk/about-us/team/ranin-soliman

Google Scholar Profile: https://scholar.google.com/citations?hl=en&user=f4YniMAAAAAJ&view_op=list_works&citft=1&email_for_op=raninsoliman2022%40gmail.com&sortby=pubdate

Ranin is the head of the Health Economics and Value Unit at CCHE. Ranin is currently a >doctoral researcher (DPhil or PhD candidate) in Evidence-based Healthcare at the University of Oxford, UK. She studied Health Economic Evaluation and Statistical Computing using R and STATA at the University of Oxford, and she studied advanced decision analytic modelling for Health Economic Evaluation at the University of York, UK. Ranin completed her Master’s degree in Health Informatics from Walden University in the US, in 2015, and is a Certified Professional in Healthcare Quality (CPHQ) from the National Association for Healthcare Quality

Ranin is currently focusing her work on generating evidence to improve childhood cancer health outcomes and resource use at Children’s Cancer Hospital Egypt (CCHE), as part of her DPhil research work. Her work generates high-quality evidence about the care of children with cancer by combining evidence generated from real-world data, evidence from the literature through systematic review (and meta-analysis) and evidence based on experts’ opinions to improve survival outcomes and resource use for children with cancer in Egypt (CCHE). The generated high-quality evidence will be integral to strategic and operational decision-making at CCHE.

Ranin’s expertise and research interests include health economic evaluation, evidence synthesis, value-based healthcare, clinical epidemiology and studying trends in variations of health outcomes, costs and resource use over time used advanced analytics.

Publications:

  1. Soliman R, Heneghan C, Boylan AM, et al. Barriers and facilitators to implementing cost-effective evidence-based childhood cancer treatment in a resource-limited setting in Egypt: A qualitative interview study. Accepted for publication in JCO Global Oncology journal.
  2. Soliman R. A context-specific conceptual framework of evidence synthesis to improve childhood cancer health outcomes and resource use in Egypt: using real-world data and addressing the implementation gaps. Cochrane Ev Synth. 2023;1:e12010.
  3. Soliman R,Oke J. and Sidhom I, et al. Cost-effectiveness of childhood cancer treatment in Egypt: Evidence-based lessons to promote high-value care in a resource-limited setting. EClinicalMedicine – Part of Lancet Discovery Science. 2022 Nov 4;55:101729
  4. Fadhil I, Soliman R, Jaffar S, Al Madhi S, Saab R, Belgaumi A, Elhaddad A. Estimated incidence, prevalence, mortality, and registration of childhood cancer (ages 0-14 years) in the WHO Eastern Mediterranean region: an analysis of GLOBOCAN 2020 data. Lancet Child Adolesc Health. 2022 Jul;6(7):466-473.
  5. Soliman R, Heneghan C, Bolous NS, Sidhom I, Ahmed S, Roberts N, Oke J, Elhaddad A. Systematic review of costs and cost-effectiveness of treatment for relapsed/refractory acute leukemia in children and young adults. Expert Rev Hematol. 2022 Apr;15(4):345-357.
  6. Raya Saab, Ranin Soliman, Asim Belgaumi, Leila Hessissen, Tezer Kutluk, Lydia Konig, Sawsan Jaffar Sawan Al Madhi, Iyad Sultan, Mhamed Harif and Nasim Pourghazian. Chapter 7: Childhood cancer in the Eastern Mediterranean Region. Cancer Control: Eastern Mediterranean Region Special Report. Accessed at: http://www.cancercontrol.info/wp-content/uploads/2022/05/72-chapter-7.pdf
  7. Soliman R, Elhaddad A, Oke J. et al. Childhood cancer hospital resource utilization and costs in Egypt, 2013–2017; patterns, trends and associated factors for 8,886 patients from Children’s Cancer Hospital–Egypt. Pediatr Blood Cancer. 2021 Sep 14:e29347.
  8. Soliman R, Elhaddad A, Oke J. et al. Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children’s Cancer Hospital Egypt. Int J Cancer. 2020 Sep 30.
  9. Soliman R, Eweida W, Zamzam M, Abouelnaga S. Scenario-based Prediction-of-Events: A New Theory Linking Strategic Planning of Healthcare Operations to the Prognosis of Medical Conditions. Health Care Current Reviews. 2017, 5:1. DOI: 10.4172/2375-4273.1000190.
  10. Soliman R, Eweida W, Zamzam M, Abouelnaga S. Delivering Healthcare and Education as Rightful Services not Commodities: A Noble Cause with Great Practical Implications at Children’s Cancer Hospital Egypt. Health Care: Current Review. Accepted for publication on March 30, 2017.
  11. Zamzam MA, Moussa EAH, Ghoneimy AE, Sherbiny ME, Zagloul MS, Taha H and Ranin Soliman et al. Outcomes and Prognostic Factors for Non-metastatic Osteosarcoma of the Extremity. SM J Pediatr. 2017; 2(2): 1013.
  12. Moussa E, Zamzam M, Kamel A, Salah, Z, Attia I, Gaber L, Soliman R, Ezzat, S. Risk Stratification and Pattern of Cardiotoxicity in Pediatric Ewing Sarcoma. J Egypt Natl Canc Inst.. Feb. 2017. doi: 10.1016/j.jnci.2016.12.001.
  13. Gehad A, Zamzam M, Zaghloul M, Kamel A, Soliman R, Zaky I, Salama A, Kamal N, ElShafiey M. Outcome of Resectable Pediatric Ewing Sarcoma of the Ribs. Journal of the Egyptian National Cancer Institute. April 2017, 29(2). DOI:10.1016/j.jnci.2017.03.002.
  14. Farghaly R, Zaki I, Gouda I, Abdelfatah M, Ghoneimy A, Sherbiny M, Soliman R, Zamzam M. Value of Dynamic Magnetic Resonance Imaging in Preoperative Evaluation of Pediatric Osteosarcoma. Egyptian Journal of Radiology and Nuclear Medicine. Science Direct. http://dx.doi.org/10.1016/j.ejrnm.2016.06.022.
  15. Alfaar A, Zamzam M, Abdalla A, Soliman R, El-Kinaai N. Childhood Ewing Sarcoma of the Orbit”. Journal of Pediatric Hematology Oncology, Vol. 37, Issue 6, 2015. Doi: 10.1097/MPH.0000000000000346.
  16. Anninga J, Jansen A, Hassan B, Amary M, Baumhoer D, Blay J, Brugieres L, Ferrari S, Jürgens H, Bielack B, Kovar H, Myklebost O, Nathrath M, Picci P, Riegman P, Schilham M, Soliman R, Stark D, Strauss S, Sydes M, Tarpey P, Thomas D, Whelan J, Wilhelm M, Zamzam M, Gelderblom H, and Bielack S. Report on European Bone Sarcoma Network Meeting: Integration of Clinical Trials with Tumor Biology. Clin Sarcoma Res. 2014, 4:4. DOI: 10.1186/2045-3329-4-4.
  17. Abdelkhalek E, Sherief L, Kamal N, Soliman R. Factors Associated with Delayed Cancer Diagnosis in Egyptian Children. Pubmed. Clin Med Insights Pediatr. 2014; 8: 39–44. doi: 10.4137/CMPed.S16413.

Conference Presentations:

  1. July 2022, Oral presentation entitled “Systematic review of costs and cost-effectiveness of treatment for relapsed/refractory acute leukaemia in children”. EBM Live Oxford 2022. BMJ Evidence-Based Medicine 2022;27: A20.
  2. July 2022, Poster presentation entitled “A methodological approach of evidence synthesis to improve childhood cancer health outcomes and resource use in Egypt”. EBM Live Oxford 2022. BMJ Evidence-Based Medicine 2022;27: A5.
  3. July 2022, Poster presentation entitled “Evidence-based medicine teaching in medical schools in the Middle East North Africa (MENA) region”. EBM Live Oxford 2022. BMJ Evidence-Based Medicine 2022;27: A4-A5.
  4. June 2021, Poster Presentation entitled, “Development of a ‘Dual Costing Model’ in hospitals and its implementation at Children’s Cancer Hospital Egypt; combining traditional and activity-base costing”. Virtual International Forum for Quality and Healthcare, Europe 2021.
  5. July 2019, Oral Presentation entitled “Childhood cancer health outcomes in Egypt: ten-year real-world evidence from children’s cancer hospital 57357 – Egypt (CCHE) and comparison with results from England”. EBM Live Oxford. 2019.
  6. July 2019, Oral Presentation entitled “Barriers and facilitators to using real-world data in healthcare settings in low-and middle-income countries: a systematic review of qualitative studies”. EBM Live Oxford 2019.
  7. March 2019, Oral Presentation entitled Using Evidence to Improve Childhood Cancer Health Outcomes and Resource Use in Egypt; Reflections from Children’s Cancer Hospital Egypt–CCHE. SIOP Africa 2019.
  8. October 2017, Oral Presentation entitled “Development of A Standardized System for Measuring Value-Based Healthcare in Osteosarcoma at Children’s Cancer Hospital Egypt”. SIOP Congress. Washington DC.
  9. June 2017 “The delivery of value-based healthcare for children with Osteosarcoma at Children’s Cancer Hospital Egypt”. ASCO Annual Meeting. J Clin Oncol 35, 2017 (suppl; abstr e18310).
  10. October 2016, Poster Presentation entitled “Frequency and Outcome of Bilateral Wilms Tumor: Experience at Children’s Cancer Hospital – Egypt 57357”. SIOP 2016. Dublin.
  11. May 2014, Oral Presentation entitled “Value of Dynamic MRI in Pre-operative Evaluation of Pediatric Bone Tumors”, European Musculoskeletal Oncology Society (EMSOS) conference, Vienna, Austria.
  12. May 2014, Poster Presentation entitled “Outcomes of Adolescent Patients with High-grade Osteosarcoma”, EMSOS conference, Vienna, Austria.